Interpreting studies of exercise and osteoporosis: A call for rigor

Controlled Clinical Trials

Volumn 18, Issue 1, 1997, Pages 54-57

  Block, Jon E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; EXERCISE; HUMAN; OSTEOPOROSIS; PHYSICAL ACTIVITY;

DATA INTERPRETATION, STATISTICAL; EXERCISE; HUMANS; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0031079781     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00039-6     Document Type: Article

References (22)

1. 1. Block JE, Smith R, Black D, Genant HK. Does exercise prevent osteoporosis? JAMA. 1987;257:3115-3117.
2. 2. Block JE, Smith R, Friedlander A, Genant HK. Preventing osteoporosis with exercise: a review with emphasis on methodology. Med Hypotheses. 1989;30:9-19.
3. 3. Block JE, Genant HK, Black D. Greater vertebral bone mineral mass in exercising young men. West J Med. 1986;145:39-42.
4. 4. Block JE, Friedlander AL, Brooks GA, Steiger P, Stubbs HA, Genant HK. Determinants of bone density among athletes engaged in weight-bearing and non-weight-bearing activity. J Appl Physiol. 1989;67:1100-1105.
5. 5. Beverly MC, Rider TA, Evans MJ, Smith R. Local bone mineral response to brief exercise that stresses the skeleton. Br Med J. 1989;299:233-235.
6. 6. Sinaki M, Wahner HW, Offord KP, Hodgson SF. Efficacy of nonloading exercises in prevention of vertebral bone loss in postmenopausal women: a controlled trial. Mayo Clin Proc. 1989;64:762-769.
7. 7. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med. 1991;325:1189-1195.
8. 8. Smidt GL, Lin SY, O'Dwyer KD, Blanpied PR. The effect of high-intensity trunk exercise on bone mineral density of postmenopausal women. Spine. 1992; 17:280-285.
9. 9. Snow-Harter C, Bouxsein ML, Lewis BT, Carter DR, Marcus R. Effects of resistance and endurance exercise on bone mineral status of young women: a randomized exercise intervention trial. J Bone Min Res. 1992;7:761-769.
10. 10. Bassey EJ, Ramsdale SJ. Weight-bearing exercise and ground reaction forces: a 12-month randomized controlled trial of effects on bone mineral density in healthy postmenopausal women. Bone. 1995;16:469-476.
11. 11. Friedlander AL, Genant HK, Sadowsky S, Byl NN, Glueer CC. A two-year program of aerobics and weight training enhances bone mineral density of young women. J Bone Min Res. 1995;10:574-585.
12. 12. Lohman T, Going S, Pamenter R, et al. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study. J Bone Min Res. 1995;10:1015-1024.
13. 13. Drinkwater BL, Grimston SK, Raab-Cullen DM, Snow-Harter CM. ACSM Position stand on osteoporosis and exercise. Med Sci Sports Exer. 1995;27:i-vii.
14. 14. Fisher LD, Dixon DO, Herson J, Frankowski RK, Hearson MS, Peace KE. Intention to treat in clinical trials. In: Peace KE, ed. Statistical Issues in Drug Research and Development. New York: Marcel Dekker; 1990:331-350.
15. 15. Heaney RP. How do we know what we know? The randomized controlled trial revisited. J Bone Min Res. 1991;6:103-105.
16. 16. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med. 1991;10:1595-1605.
17. 17. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol. 1992;21:837-841.
18. 18. Yusuf S, Garg R, Zucker D. Analysis by the intention-to-treat principle in randomized trials and data bases. PACE. 1991;14:2078-2082.
19. 19. Yusuf S, Wittes J, Probstfield J, Tyroler H. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
20. 20. Lewis JA, Machin D. Intention to treat - who should use ITT? Br J Cancer. 1993; 68:647-650.
21. 21. The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303:1038-1041.
22. 22. Food and Drug Administration. Guidelines for preclinical and clinical evaluation of agents used in the prevention and treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products (draft). 1994;1-20.